NDC 61755-014 – Veopoz
Pozelimab 200 mg/mL · Injection, Solution · Intravenous, Subcutaneous
Product NDC61755-014
Product details
- Brand name
- Veopoz
- Generic name
- Pozelimab
- Labeler
- Regeneron Pharmaceuticals, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Marketing category
- BLA · BLA761339
- Marketed since
- August 18, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Complement Inhibitor
Active ingredients
- Pozelimab 200 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61755-014-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01) / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00) | Aug 18, 2023 |